Combined androgen blockade in prostate cancer: meta-analyses and associated issues.
Klotz
L
L
Sunnybrook & Women's College Health Sciences Centre, University of Toronto, Canada. laurence.klotz@swchsc.on.ca
D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D012307:Risk Factors; D012680:Sensitivity and Specificity
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal